WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1632972
PLYMOUTH, MN
Position in DNA
as of Mar 31, 2026
· filed Apr 8, 2026
Position Value
$72,989
New position
Shares Held
11,907
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 1.763668430335097.ToString("F0")%
Shared 0.ToString("F0")%
None 98.2363315696649.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $121,469,578 across 107 Biotechnology names. DNA ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
37,596 | $29,048,173 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
40,668 | $18,159,888 | |
| 3 | INCY |
Incyte Corp
|
146,306 | $13,770,320 | |
| 4 | EXEL |
Exelixis, Inc.
|
206,578 | $8,860,130 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
112,375 | $6,348,063 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
19,180 | $3,241,803 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
46,665 | $3,015,958 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,478 | $2,805,115 |
All Filings in DNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $72,989 | 11,907 | Shares | Sole | 2026-04-08 | |
| No filing history on record for this holder in this stock. | ||||||